More than 40% of the 1.3 million U.S. adults with rheumatoid arthritis (RA) get no exercise, according to a study published in the journal Arthritis Care Research.

Pain management is a high priority for patients with rheumatoid arthritis, so three researchers in Australia analyzed existing study data to see whether two different classes of drugs can help. When looking at muscle relaxants, they discovered that neither the benzodiazepine agents, diazepam and triazolam, nor the non- benzodiazepine agent, zopiclone, reduce pain when taken for one to 14 days ...

An experimental pill called tofacitinib appears to reduce the pain and swelling of rheumatoid arthritis just as well as Humira injections, researchers say.

Women under 50 with rheumatoid arthritis (RA) are more than twice as likely to break a bone as those without the condition, a large study shows.

Results of Amgen's second and final period of the PRESERVE trial have been announced. PRESERVE is a two-period multi-center trial in individuals suffering from moderately active rheumatoid arthritis (RA). Participants in the trial achieved clinical remission on Enbrel® (etanercept) or methotrexate (MTX) combined or a Disease Activity Score (DAS) of 28 low disease activity (LDA) in period one. In ...